Studies involving disease:Kidney disease
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST000050 | Preterm Neonatal Urinary Renal Developmental and acute kidney injury Metabolomic Profiling | Human | University of North Carolina |
| ST000329 | Minimal change disease and focal segmental sclerosis in urine | Human | University of California, Davis |
| ST000560 | Metabolomics of immunoglobulin-producing cells in IgA nephropathy | Human | RTI International |
| ST000565 | Association of hemodialysis patient plasma trace metals with response to erythropoiesis stimulating agents | Human | RTI International |
| ST000691 | Metabolomics of diabetic nephropathy | Human | University of Michigan |
| ST000878 | Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease | Mouse | University of California, Davis |
| ST000978 | Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: results from the Progredir Cohort. | Human | University of Sao Paulo |
| ST001153 | Erythrocyte adenosine A2B receptor-mediated AMPK activation: Counteracting CKD by promoting oxygen delivery | Mouse | University of Texas Health Science Center at Houston |
| ST001361 | Serum tryptophan metabolomics in CKD | Mouse | University of Florida |
| ST001855 | The metabolomic resetting effect of FG4592 in AKI to CKD transition (Part 1) | Mouse | Children's Hospital of Nanjing Medical University |
| ST001856 | The metabolomic resetting effect of FG4592 in AKI to CKD transition (Part 2) | Mouse | Children's Hospital of Nanjing Medical University |
| ST002403 | Deep multi-omic profiling reveals extensive mitochondrial remodeling driven by glycemia in early diabetic kidney disease (Mitochondria) | Rat | Baker Heart and Diabetes Institute |
